beta-synucleinADAlzheimer’s diseaseKong and Jung2
… advances in neurodegenerative biomarker research shed light on beta-synuclein as a promising indicator of synaptic dysfunction in Alzheimer’s…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… advances in neurodegenerative biomarker research shed light on beta-synuclein as a promising indicator of synaptic dysfunction in Alzheimer’s…
…gy as evidenced by CSF analysis (p<0.001).Conclusion High serum beta-synuclein level is a promising biomarker for AD-related synaptic damage.…